Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Muhlenkamp Fund (MUHLX)

57.49
Net Asset Value
+0.52%
1 Day
+18.61%
Year-to-Date
Overall Morningstar Rating
Large blend
Style or Category
No Load
Sales Expenses
1.30%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks to maximize total after-tax return to its shareholders through capital appreciation- and income from dividends and interest- consistent with reasonable risk. The fund principally invests in a diversified list of common stocks of companies of any capitalization- determined by the investment adviser to be highly profitable- yet undervalued. Muhlenkamp & Company- Inc. (the "Adviser") looks for companies the advisor believes to have above-average profitability- as measured by corporate return-on-equity- and that sell at below-average prices- as measured by price-to-earnings-ratios.

Performance

1 month+2.53% 3 years+2.77%
3 months+5.41% 5 years+7.86%
1 year+17.18% Since inception+9.07%
Data through --

Peer Comparisonvs. Large blend

 MUHLXCategory
Performance 5-yr return+7.86%+12.91%
Expense ratio1.30%0.98%
Risk 5 year sharpe ratio0.751.37
Net assets$262.2M$5.3B
Average market cap$32.4B$132.8B
Average P/E17.422.2
Portfolio turnover40%40%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyMuhlenkamp
Fund manager & tenureRonald Muhlenkamp / 29 Years
Minimal initial investment$1,500.00
Minimum IRA investment--

Holdings

U.S. stock77.75%
International stock10.62%
Cash8.37%
Fixed income3.26%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 28.02%
Telecommunication 15.23%
Consumer goods 12.73%
Consumer service 9.80%
Financial service 7.96%
Top 10 Holdings
Portfolio weighting
AAPL Apple7.64%
ON ON Semiconductor Corp7.57%
MSFT Microsoft5.87%
GILD Gilead Sciences5.75%
ADS Alliance Data Systems Corp4.82%
RUSHA Rush Enterprises Inc4.52%
BMY Bristol-Myers Squibb3.77%
UNH UnitedHealth3.63%
CE Celanese Corp3.62%
HBI HanesBrands Inc3.52%